These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18264015)

  • 1. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
    Vlaar AM; van Kroonenburgh MJ; Kessels AG; Weber WE
    BMC Neurol; 2007 Sep; 7():27. PubMed ID: 17764571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.
    Vlaar AM; de Nijs T; van Kroonenburgh MJ; Mess WH; Winogrodzka A; Tromp SC; Weber WE
    BMC Neurol; 2008 Nov; 8():42. PubMed ID: 18992168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
    Hauser RA; Grosset DG
    J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.
    Kahraman D; Eggers C; Schicha H; Timmermann L; Schmidt M
    J Neurol; 2012 Feb; 259(2):251-60. PubMed ID: 21750954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.
    Pirker W; Djamshidian S; Asenbaum S; Gerschlager W; Tribl G; Hoffmann M; Brücke T
    Mov Disord; 2002 Jan; 17(1):45-53. PubMed ID: 11835438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease.
    Stoffers D; Booij J; Bosscher L; Winogrodzka A; Wolters EC; Berendse HW
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):689-95. PubMed ID: 15682332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up.
    Hambÿe AS; Vervaet A; Dethy S
    Nucl Med Commun; 2010 Jun; 31(6):583-9. PubMed ID: 20429096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.
    Tolosa E; Borght TV; Moreno E;
    Mov Disord; 2007 Dec; 22(16):2346-51. PubMed ID: 17914722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 123I-iodobenzamide SPECT is not an independent predictor of dopaminergic responsiveness in patients with suspected atypical parkinsonian syndromes.
    Hellwig S; Kreft A; Amtage F; Tüscher O; Winz OH; Hellwig B; Weiller C; Weber WA; Vach W; Meyer PT
    J Nucl Med; 2013 Dec; 54(12):2081-6. PubMed ID: 24115529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases.
    Sixel-Döring F; Liepe K; Mollenhauer B; Trautmann E; Trenkwalder C
    J Neurol; 2011 Dec; 258(12):2147-54. PubMed ID: 21547379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
    Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
    Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.
    Bajaj N; Hauser RA; Grachev ID
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1288-95. PubMed ID: 23486993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.
    Bairactaris C; Demakopoulos N; Tripsianis G; Sioka C; Farmakiotis D; Vadikolias K; Heliopoulos I; Georgoulias P; Tsougos I; Papanastasiou I; Piperidou C
    J Clin Neurosci; 2009 Feb; 16(2):246-52. PubMed ID: 19097795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes.
    Albert NL; Unterrainer M; Diemling M; Xiong G; Bartenstein P; Koch W; Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu LÖ; Kluge A; Ziebell M; Darcourt J; Nobili F; Pagani M; Sabri O; Hesse S; Borght TV; Van Laere K; Tatsch K; la Fougère C
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1315-22. PubMed ID: 26780619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Parkinsonian syndromes with very poor striatal uptake on 123I-ioflupane SPECT imaging.
    Dibble EH; Yoo DC; Noto RB; Friedman JH
    Clin Nucl Med; 2015 Feb; 40(2):e152-6. PubMed ID: 25546212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.